ProShare Advisors
URGN icon

ProShare Advisors’s UroGen Pharma URGN Stock Holding History

ProShare Advisors’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,812
Closed -$206K – 2029
2025
Q4 		$206K Buy
+8,812
New +$191K ﹤0.01% 1698
2025
Q2 		– Sell
-10,279
Closed -$114K – 2191
2025
Q1 		$114K Sell
10,279
-2,616
-20% -$27.9K ﹤0.01% 1809
2024
Q4 		$137K Buy
+12,895
New +$154K ﹤0.01% 1997
2024
Q3 		– Sell
-11,888
Closed -$199K – 2109
2024
Q2 		$199K Buy
+11,888
New +$169K ﹤0.01% 1531
2020
Q1 		– Sell
-7,077
Closed -$236K – 1572
2019
Q4 		$236K Buy
+7,077
New +$193K ﹤0.01% 1487
2019
Q3 		– Sell
-6,068
Closed -$218K – 1694
2019
Q2 		$218K Sell
6,068
-887
-13% -$32.7K ﹤0.01% 1392
2019
Q1 		$257K Buy
6,955
+1,710
+33% +$71.7K ﹤0.01% 1336
2018
Q4 		$226K Buy
+5,245
New +$236K ﹤0.01% 1306

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return